Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Indoco Remedies LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532612NSE Symbol: INDOCOP/E(TTM):0
ISIN Demat:INE873D01024Div & Yield %:0.09EPS(TTM):0
Book Value(Rs):118.2010129Market Cap ( Cr.):2017.46Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1518.191790.811666.691539.721240.301105.99
Excise Duty0.000.000.000.000.000.00
Net Sales1518.191790.811666.691539.721240.301105.99
Other Income 19.4828.242.332.323.112.43
Stock Adjustments 32.0414.70-6.5526.3012.138.05
Total Income1569.711833.751662.471568.341255.541116.47
EXPENDITURE :      
Raw Materials 475.72561.15514.74483.05366.20338.48
Power & Fuel Cost53.4555.3150.6142.7836.8934.75
Employee Cost 368.74350.55321.15294.95272.88255.32
Other Manufacturing Expenses 91.60116.7289.7060.6646.0744.38
Selling and Administration Expenses 387.49407.12340.26293.42258.53287.83
Miscellaneous Expenses 45.1964.8658.7964.1548.2929.95
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1422.191555.721375.251239.021028.86990.70
Operating Profit147.50278.02287.22329.32226.69125.77
Interest 56.6336.8125.0314.1422.2226.25
Gross Profit90.87241.21262.19315.18204.4799.52
Depreciation98.2587.9870.6078.9573.1270.81
Profit Before Tax-7.38153.23191.59236.23131.3528.71
Tax0.0032.7755.2093.2338.473.86
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.363.81-4.97-11.520.480.60
Reported Net Profit-8.74116.64141.36154.5292.3924.25
Extraordinary Items 1.158.49-0.90-0.31-0.17-0.19
Adjusted Net Profit-9.89108.15142.26154.8392.5624.44
Adjst. below Net Profit -4.490.041.44-5.33-0.86-2.41
P & L Balance brought forward781.49685.55563.48428.11339.35320.27
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 13.8320.7320.7313.822.762.76
P & L Balance carried down754.44781.49685.55563.48428.11339.35
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %10.0075.00112.50112.5075.0015.00
Earnings Per Share-Unit Curr-0.9512.6515.3416.7710.032.63
Earnings Per Share(Adj)-Unit Curr-0.9512.6515.3416.7710.032.63
Book Value-Unit Curr119.61122.22111.4598.1383.4473.81